Rik Bryan

Accepting PhD Students

PhD projects

Rik Bryan has an interest in all aspects of bladder cancer, from optical technologies and surgical techniques to biomarker discovery and molecular pathways. He has a track record of research and publication in the following areas:

Biomarker discovery: Proteomic and metabolomic analyses of urine; tissue array-based immunohistochemical analyses of multiple molecular markers; next-generation sequencing of tumour tissue
Bladder tumour immunology: Basic science and responses to BCG therapy
Pathway-based research: Investigation of the potential links between cadherin switching and bladder cancer stem cells; tumour hypoxia pathways
Narrow band imaging cystoscopy: Trial-based investigation of the utility of NBI in bladder tumour resection and subsequent disease surveillance

Research activity per year

1 - 50 out of 154 results

2024
Comparison and combination of mutation and methylation-based urine tests for bladder cancer detection
Gordon, N. S., McGuigan, E. K., Ondasova, M., Knight, J., Baxter, L. A., Ott, S., Hastings, R. K., Zeegers, M. P., James, N. D., Cheng, K. K., Goel, A., Yu, M., Arnold, R., Bryan, R. T. & Ward, D. G., 7 Nov 2024, In: Biomarker Research. 12, 1, 4 p., 133.
Research output: Contribution to journal › Letter › peer-review

Open Access
File
11 Downloads (Pure)
Image directed redesign of bladder cancer treatment pathways: the BladderPath RCT
James, N., Pirrie, S., Liu, W., Catto, J., Jefferson, K., Patel, P., Hughes, A., Pope, A., Nanton, V., Mintz, H. P., Knight, A., Gallagher, J. & Bryan, R. T., 31 Aug 2024, In: Health Technology Assessment. 28, 42, p. 1-65 65 p.
Research output: Contribution to journal › Article › peer-review

Open Access
File
14 Downloads (Pure)
Improved Disease Free Survival With Adjuvant Chemotherapy After Nephroureterectomy for Upper Tract Urothelial Cancer: Final Results of the POUT Trial
Birtle, A., Jones, R., Chester, J., Lewis, R., Biscombe, K., Johnson, M., Blacker, A., Bryan, R., Catto, J. W. F., Choudhury, A., Das, P., Jagdev, S., Powles, T., Wagstaff, J., Chung, K. C., Cafferty, F. & Hall, E. C., 13 Feb 2024, (E-pub ahead of print) In: Journal of Clinical Oncology .
Research output: Contribution to journal › Article › peer-review

Open Access
File
46 Downloads (Pure)
Low-grade urothelial carcinoma recurs at a tempo that naturally accelerates over time
Sankin, A., Dave, P., Cherrill, L.-R., Boucher, R. H., Zeegers, M. P., Cheng, K. K., James, N. D., Agalliu, I. & Bryan, R. T., 18 Jul 2024, (E-pub ahead of print) In: Urology.
Research output: Contribution to journal › Article › peer-review
2023
Boosting and broadening recruitment to UK cancer trials: towards a blueprint for action
Nanton, V., Bryan, R., Pope, A., Hughes, A., Jefferson, K., Catto, J., Knight, A., Gallagher, J., Mintz, H., Pirrie, S., Liu, W., Young, A., Patel, P. & James, N., 20 Nov 2023, In: BMJ Oncology. 2, 1, 10 p., e000092.
Research output: Contribution to journal › Review article › peer-review

Open Access
File
43 Downloads (Pure)
Elevated levels of MMP12 sourced from macrophages are associated with poor prognosis in urothelial bladder cancer
Kerzeli, I. K., Kostakis, A., Türker, P., Malmström, P.-U., Hemdan, T., Mezheyeuski, A., Ward, D. G., Bryan, R. T., Segersten, U., Lord, M. & Mangsbo, S. M., 30 Jun 2023, In: BMC Cancer. 23, 1, 13 p., 605.
Research output: Contribution to journal › Article › peer-review

Open Access
File
73 Downloads (Pure)
Making administrative healthcare systems clinical data the future of clinical trials: lessons from BladderPath
Mintz, H. P., Dosanjh, A. R. S., Parsons, H., Sydes, M., Bryan, R. T., James, N. D. & Patel, P., 17 Jul 2023, In: BMJ Oncology. 2, 1, e000038.
Research output: Contribution to journal › Editorial › peer-review

Open Access
File

42 Downloads (Pure)
Properties of non-coding mutation hotspots as urinary biomarkers for bladder cancer detection
The BladderPath trial management group, 19 Jan 2023, In: Scientific Reports. 13, 1, 7 p., 1060.
Research output: Contribution to journal › Article › peer-review

Open Access
File
76 Downloads (Pure)
Selenium and Vitamin E for Prevention of Non–Muscle-Invasive Bladder Cancer Recurrence and Progression: A Randomized Clinical Trial
SELENIB Investigators, Bryan, R., Pirrie, S., Abbotts, B., Maycock, S., During, V., Lewis, C., Grant, M., Bird, D., Devall, A., Wallace, D. M., James, N., Billingham, L., Zeegers, M. & Cheng, K., 17 Oct 2023, In: JAMA network open. 6, 10, 10 p., e2337494.
Research output: Contribution to journal › Article › peer-review

Open Access
File
55 Downloads (Pure)
The sex gap in bladder cancer survival: a missing link in bladder cancer care?
Toren, P., Wilkins, A., Patel, K., Burley, A., Gris, T., Kockelbergh, R., Lodhi, T., Choudhury, A. & Bryan, R. T., 21 Aug 2023, (E-pub ahead of print) In: Nature reviews. Urology. 12 p.
Research output: Contribution to journal › Review article › peer-review

Open Access
File
35 Downloads (Pure)
2022
Combined exome and transcriptome sequencing of non-muscle-invasive bladder cancer: associations between genomic changes, expression subtypes, and clinical outcomes
Goel, A., Ward, D. G., Noyvert, B., Yu, M., Gordon, N. S., Abbotts, B., Colbourne, J. K., Kissane, S., James, N. D., Zeegers, M. P., Cheng, K. K., Cazier, J.-B., Whalley, C. M., Beggs, A. D., Palles, C., Arnold, R. & Bryan, R. T., Dec 2022, In: Genome medicine. 14, 1, 16 p., 59 .
Research output: Contribution to journal › Article › peer-review

Open Access
File
106 Downloads (Pure)
Evidence or prejudice? Critical re-analysis of randomized controlled trials comparing overall survival after cisplatin versus carboplatin-based regimens in advanced urothelial carcinoma
Richters, A., Kiemeney, L. A. L. M., Mehra, N., Westgeest, H. M., Birtle, A., Bryan, R. T. & Aben, K. K. H., 21 Jul 2022, In: Clinical Genitourinary Cancer. 20, 4, p. e346-e352 7 p.
Research output: Contribution to journal › Article › peer-review

Open Access
File
66 Downloads (Pure)
Genome-wide meta-analysis identifies novel genes associated with recurrence and progression in non-muscle-invasive bladder cancer
Galesloot, T. E., Grotenhuis, A. J., Kolev, D., Aben, K. K., Bryan, R. T., Catto, J. W. F., Cheng, K. K., Conroy, S., Dyrskjøt, L., Fleshner, N. E., James, N. D., Lamy, P., Lindskrog, S. V., Malats, N., Mengual, L., Verhaegh, G., Zeegers, M. P., Kiemeney, L. A. L. M. & Vermeulen, S. H., Feb 2022, In: European Urology Oncology. 5, 1, p. 70-83
Research output: Contribution to journal › Article › peer-review

Open Access
File
102 Downloads (Pure)
Highly sensitive and specific detection of bladder cancer via targeted ultra-deep sequencing of urinary DNA
BladderPath Trial Management Group, 8 Apr 2022, (E-pub ahead of print) In: European Urology Oncology. s2588-9311(22)00036-0.
Research output: Contribution to journal › Article › peer-review

Open Access
File
83 Downloads (Pure)
Immunotherapy for non-muscle invasive bladder cancer: from the origins of BCG to novel therapies
Unsworth-White, S., Kitchen, M. & Bryan, R., 1 Jan 2022, In: Future Oncology. 18, 1, p. 105-115 11 p.
Research output: Contribution to journal › Review article › peer-review

Open Access
File
122 Downloads (Pure)
Novel intravesical therapeutics in the treatment of non-muscle invasive bladder cancer: horizon scanning
Ward, K., Kitchen, M., Mathias, S.-J., Khanim, F. & Bryan, R., 26 Jul 2022, In: Frontiers in Surgery. 9, 14 p., 912438.
Research output: Contribution to journal › Review article › peer-review

Open Access
File
133 Downloads (Pure)
Patients choose certainty over burden in bladder cancer surveillance
Van Osch, F., Nekeman, D., Aaronson, N., Billingham, L., James, N., Cheng, K., Bryan, R. & Zeegers, M., Dec 2022, In: World Journal of Urology. 37, 12, p. 2747-2753 7 p.
Research output: Contribution to journal › Article › peer-review

Open Access
File
2 Citations (Scopus)

141 Downloads (Pure)
Scoping review: bladder cancer in Nigeria - what are the gaps in clinical care and research?
Iya, A., Beyer, K., Kotecha, P., Kibaru, J., Abdullahi, M., Alhassan, S., Mustapha, M., Ahmad, A., Lawal, Y., Jalo, R., Aminu, A., Abubakar, A., Saleh, A., Bryan, R., Van Hemelrijck, M. & Russell, B., 8 Mar 2022, In: BMJ open. 12, 3, p. 1-11 11 p., e049241.
Research output: Contribution to journal › Article › peer-review

Open Access
File
43 Downloads (Pure)
STAG2 protein expression in non-muscle-invasive bladder cancer: associations with sex, genomic and transcriptomic changes, and clinical outcomes
Gordon, N., Humayun-Zakaria, N., Goel, A., Abbotts, B., Zeegers, M. P., Cheng, K., Arnold, R., James, N. D., Bryan, R. & Ward, D., Apr 2022, In: European Urology Open Science. 38, p. 88-95 8 p.
Research output: Contribution to journal › Article › peer-review

Open Access
File
102 Downloads (Pure)
The experience of UK patients with bladder cancer during the second wave of the COVID-19 pandemic
Spencer-Bowdage, S., Russell, B., Rigby, J., O'Kelly, J., Kelly, P., Page, M., Raw, C., Allchorne, P., Harper, P. G., Crew, J., Kockelbergh, R., Knight, A., Van Hemelrijck, M. & Bryan, R., 17 May 2022, (E-pub ahead of print) In: BJUI Compass. 3 p.
Research output: Contribution to journal › Article › peer-review

Open Access
File

85 Downloads (Pure)
Urine DNA for monitoring chemoradiotherapy response in muscle-invasive bladder cancer: a pilot study
Gordon, N. S., Baxter, L. A., Goel, A., Arnold, R., Kaur, B., Liu, W., Pirrie, S. J., Hussain, S., Viney, R., Ford, D., Zarkar, A., Wood, M. A., Mitin, T., Thompson, R. F., James, N. D., Ward, D. G. & Bryan, R. T., 1 Jan 2022, In: BJU International . 129, 1, p. 32-34 3 p.
Research output: Contribution to journal › Article › peer-review

Open Access
File

156 Downloads (Pure)
2021
An integrated multi-omics analysis identifies prognostic molecular subtypes of non-muscle-invasive bladder cancer
Lindskrog, S., Prip, F., Lamy, P., Taber, A., Groeneveld, C., Birkenkamp-Demtröder, K., Jensen, J., Strandgaard, T., Nordentoft, I., Christensen, E., Sokac, M., Birkbak, N., Maretty, L., Hermann, G., Petersen, A., Weyerer, V., Grimm, M., Horstmann, M., Sjödahl, G. & Höglund, M. & 27 others, Steiniche, T., Mogensen, K., de Reyniès, A., Nawroth, R., Jordan, B., Lin, X., Dragicevic, D., Ward, D., Goel, A., Hurst, C. D., Raman, J., Warrick, J., Segersten, U., Sikic, D., van Kessel, K., Maurer, T., Meeks, J., DeGraff, D., Bryan, R., Knowles, M. A., Simic, T., Hartmann, A., Zwarthoff, E., Malmström, P., Malats, N., Real, F. & Dyrskjøt, L., 16 Apr 2021, In: Nature Communications. 12, 18 p., 2301.
Research output: Contribution to journal › Article › peer-review

Open Access
File
303 Downloads (Pure)
A systematic review of outcome reporting, definition and measurement heterogeneity in non-muscle invasive bladder cancer effectiveness trials of adjuvant, prophylactic treatment after transurethral resection
Veskimae, E., Subbarayan, S., Campi, R., Carron, D., Omar, M. I., Yuan, C., Dimitropoulos, K., Van Hemelrijck, M., Bryan, R., N'Dow, J., Babjuk, M., Witjes, J. A., Sylvester, R. & MacLennan, S., 25 May 2021, In: Bladder Cancer. 7, 2, p. 221-241 21 p.
Research output: Contribution to journal › Article › peer-review

Open Access
File
197 Downloads (Pure)
Comparing an imaging-guided pathway with the standard pathway for staging muscle-invasive bladder cancer: preliminary data from the BladderPath study
Bryan, R., Liu, W., Pirrie, S., Amir, R., Gallagher, J., Hughes, A., Jefferson, K., Knight, A., Nanton, V., Mintz, H., Pope, A., Catto, J., Patel, P. & James, N., 10 Jun 2021, In: European urology. 80, 1, p. 12-15 4 p.
Research output: Contribution to journal › Article › peer-review

Open Access
File
3 Citations (Scopus)

148 Downloads (Pure)
Designing a pragmatic intervention to help improve the bladder cancer patient experience
Bessa, A., Bosco, C., Cahill, F., Russell, B., Fox, L., Moss, C., Wylie, H., Haire, A., Green, S., Enting, D., Khan, S., Nair, R., Thurairaja, R., Chatterton, K., Amery, S., Peat, N., Smith, S., Spear, S., Bryan, R. T. & Frodsham, L. & 7 others, Burke, D., Rigby, J., Makaroff, L., Kelly, P., Costin, M., Häggström, C. & Van Hemelrijck, M., 16 Jul 2021, In: Inquiry : The Journal of Health Care Organization, Provision, and Financing. 58, 8 p., 469580211030217.
Research output: Contribution to journal › Article › peer-review

Open Access
File
101 Downloads (Pure)
Establishing the Bladder Cancer Research Centre at the University of Birmingham
Bryan, R. T., Arnold, R., Khanim, F. L., Shepherd, D. E., Patel, P. & Ward, D. G., Jun 2021, In: Nature Reviews Urology. 18, 6, p. 318-320 3 p.
Research output: Contribution to journal › Comment/debate › peer-review

Open Access
File

102 Downloads (Pure)
PD-L2 is constitutively expressed in normal and malignant urothelium
Dowell, A., Munford, H., Goel, A., Gordon, N., James, N., Cheng, K., Zeegers, M., Ward, D. & Bryan, R., 25 Feb 2021, In: Frontiers in Oncology. 11, 7 p., 626748.
Research output: Contribution to journal › Article › peer-review

Open Access
File
166 Downloads (Pure)
Reply to Trey Durdin, Alvin Goh, and Eugene Pietzak. Can an imaging-guided pathway replace the current paradigm for muscle-invasive bladder cancer?
BladderPath Trial Management Group, Jul 2021, In: European urology. 80, 1, p. 18-19 2 p.
Research output: Contribution to journal › Comment/debate › peer-review

Open Access
File

57 Downloads (Pure)
Risk of bladder cancer death in patients younger than 50 with non-muscle-invasive and muscle-invasive bladder cancer
Russell, B., Liedberg, F., Hagberg, O., Ullen, A., Soderkvist, K., Strock, V., Aljabery, F., Gardmark, T., Jerlstrom, T., Sherif, A., Holmberg, L., Bryan, R., Enting, D. & Van Hemelrijck, M., 13 Nov 2021, In: Scandinavian Journal of Urology and Nephrology. 56, 1, p. 27-33 7 p.
Research output: Contribution to journal › Article › peer-review

Open Access
File
113 Downloads (Pure)
Scoping Review protocol: Bladder cancer in Nigeria - what are the gaps in clinical care and research?
Kibaru, J., Kotecha, P., Iya, A., Russell, B., Abdullahi, M., Alhassan, S., Mustapha, M., Bryan, R. & Van Hemelrijck, M., 31 Jan 2021, In: BMJ open. 11, 1, 5 p., e041894.
Research output: Contribution to journal › Article › peer-review

Open Access
File
181 Downloads (Pure)
Switching cancers: a systematic review assessing the role for androgen suppressive therapy in bladder cancer
Kourbanhoussen, K., McMartin, C., Lodde, M., Zlotta, A., Bryan, R. & Toren, P., 25 Sept 2021, In: European Urology Focus. 7, 5, p. 1044-1051 8 p.
Research output: Contribution to journal › Review article › peer-review

Open Access
File
148 Downloads (Pure)
Systematic review of the association between socioeconomic status and bladder cancer survival with hospital type, comorbidities, and treatment delay as mediators
Russell, B., Haggstrom, C., Holmberg, L., Liedberg, F., Gårdmark, T., Bryan, R., Kumar, P. & Van Hemelrijck, M., 7 Jan 2021, (E-pub ahead of print) In: BJUI Compass.
Research output: Contribution to journal › Article › peer-review

Open Access
File
208 Downloads (Pure)
The experience of UK patients with bladder cancer during the COVID-19 pandemic: a survey-based snapshot
Spencer-Bowdage, S., Russell, B., Rigby, J., O'Kelly, J., Kelly, P., Page, M., Raw, C., Allchorne, P., Harper, P., Crew, J., Kockelbergh, R., Knight, A., Van Hemelrijck, M. & Bryan, R., Feb 2021, In: BJU International . 127, 2, p. 179-181 3 p.
Research output: Contribution to journal › Article › peer-review

Open Access
File

197 Downloads (Pure)
The need for supportive mental wellbeing interventions in bladder cancer patients: a systematic review of the literature
Bessa, A., Rammant, E., Enting, D., Bryan, R., Khan, M. S., Malde, S., Nair, R., Thurairaja, R., Cahill, F., Amery, S., Smith, S., Ahmed, K., Russell, B., Moss, C., Chatterton, K., Haggstrom, C. & Van Hemelrijck, M., 28 Jan 2021, In: PLoS ONE. 16, 1, e0243136.
Research output: Contribution to journal › Review article › peer-review

Open Access
File
220 Downloads (Pure)
The Scottish Bladder Cancer Quality Performance Indicators Influencing Outcomes, Prognosis, and Surveillance (Scot BC Quality OPS) Clinical Project
Mariappan, P., Ahmad, I., Amer, T., Andersen, L. D., Baker, S., Bhatt, J., Brown, M., Bryan, R., Catto, J. W. F., Chahal, R., Chapman, A., Chaudhry, A., Desouza, J., Dimitropoulos, K., Dreyer, B., Gourley, C., Gray, N. S. J., Hamid, S., Hanchanale, V. & Harrison, E. & 32 others, Hasan, R., Hendry, D., Hollins, G., Hussain, S. A., Johnson, M., Johnston, A., Jones, R., Kandaswamy, M. G. V., Kelly, J., Khan, R., Kotwal, S., Kumar, P., Kumar, V., Laing, K., Lord-mckenzie, N. S. T., Maclennan, S., Makaroff, L., Mitchell, I. D. C., Morrison, D., Nair, R., Nandwani, G. M., Norrie, J., Ramsey, S., Scowcroft, H., Sharpe, C. N. S. C., Sridhar, A. N., Thomas, B. G., Thurairaja, R., Trail, M., Hemelrijck, M. V., Vasdev, N. & Simpson, H., Sept 2021, In: European Urology Focus. 7, 5, p. 905-908 4 p.
Research output: Contribution to journal › Article › peer-review
The sirenic links between diabetes, obesity, and bladder cancer
Gill, E., Sandhu, G., Ward, D., Perks, C. M. & Bryan, R., 15 Oct 2021, In: International Journal of Molecular Sciences. 22, 20, 11150.
Research output: Contribution to journal › Review article › peer-review

Open Access
File
79 Downloads (Pure)
Trends in urine biomarker discovery for urothelial bladder cancer: DNA, RNA, or protein?
Humayun-Zakaria, N., Ward, D. G., Arnold, R. & Bryan, R. T., 27 Jun 2021, In: Translational Andrology and Urology. 10, 6, p. 2787-2808 22 p.
Research output: Contribution to journal › Review article › peer-review

Open Access
File
170 Downloads (Pure)
2020
Adjuvant chemotherapy in upper tract urothelial carcinoma (the POUT trial): a phase 3, open-label, randomised controlled trial
Birtle, A., Johnson, M., Chester, J., Jones, R., Dolling, D., Bryan, R., Harris, C., WInterbottom, A., Blacker, A., Catto, J., Chakraborti, P., Donovan, J., Elliott, P., French, A., Jagdev, S., Jenkins, B., Keeley, F., Kockelbergh, R., Powles, T. & Wagstaff, J. & 4 others, Wilson, C., Todd, R., Lewis, R. & Hall, E., 18 Apr 2020, In: The Lancet. 395, 10232, p. 1268-1277 10 p.
Research output: Contribution to journal › Article › peer-review

Open Access
File
77 Citations (Scopus)

273 Downloads (Pure)
Aryloxy Diester Phosphonamidate Prodrugs of Phosphoantigens (ProPAgens) as Potent Activators of Vγ9/Vδ2 T-Cell Immune Responses
Kadri, H., Taher, T. E., Xu, Q., Sharif, M., Ashby, E., Bryan, R. T., Willcox, B. E. & Mehellou, Y., 8 Oct 2020, In: Journal of Medicinal Chemistry. 63, 19, p. 11258-11270 13 p.
Research output: Contribution to journal › Article › peer-review
Aryloxy diester phosphonamidate prodrugs of phosphoantigens (ProPAgens) as potent activators of Vγ9/Vδ2 T‐cell immune responses
Kadri, H., Taher, T., Xu, Q., Sharif, M., Ashby, E., Bryan, R., Willcox, B. & Mehellou, Y., 8 Oct 2020, In: Journal of Medicinal Chemistry. 63, 19, p. 11258-11270
Research output: Contribution to journal › Article › peer-review
A systematic review and meta-analysis of delay to radical cystectomy and the effect on survival in bladder cancer patients
Russell, B., Liedberg, F., Shamim Khan, M., Nair, R., Thurairaja, R., Malde, S., Kumar, P., Bryan, R. & Van Hemelrijck, M., Apr 2020, In: European Urology Oncology. 3, 2, p. 239-249 11 p.
Research output: Contribution to journal › Article › peer-review

Open Access
File
20 Citations (Scopus)

367 Downloads (Pure)
Back-splicing transcript isoforms (circular RNAs) affect biologically relevant pathways and offer an additional layer of information to stratify NMIBC patients
Goel, A., Ward, D., Gordon, N., Abbotts, B., Zeegers, M., Cheng, K., James, N., Bryan, R. & Arnold, R., 22 May 2020, In: Frontiers in Oncology. 10, 10 p., 812.
Research output: Contribution to journal › Article › peer-review

Open Access
File
2 Citations (Scopus)

173 Downloads (Pure)
Bilirubin is not associated with urinary bladder cancer risk and prognosis: A Mendelian Randomization Study in the UK Biobank
Lipunova, N., Bryan, R. T. & Zeegers, M. P., 14 Aug 2020
Research output: Other contribution
Development and validation of a follow-up methodology for a randomised controlled trial, utilising routine clinical data as an alternative to traditional designs: a pilot study to assess the feasibility of use for the BladderPath trial
Mintz, H., Dosanjh, A., Parsons, H., Hughes, A., Jakeman, A., Pope, A., Bryan, R., James, N. & Patel, P., 31 Oct 2020, In: Pilot and Feasibility Studies. 6, 12 p., 165.
Research output: Contribution to journal › Article › peer-review

Open Access
File
1 Citation (Scopus)

228 Downloads (Pure)
Fluid intake and clinicopathological characteristics of bladder cancer: the West Midlands Bladder Cancer Prognosis Programme (BCPP)
van Hensbergen, M., Van Osch, F., Jochems, S., James, N., Wallace, D. M. A., Wesselius, A., Cheng, K., Bryan, R. & Zeegers, M., Mar 2020, In: European Journal of Cancer Prevention. 29, 2, p. 110-118
Research output: Contribution to journal › Article › peer-review

Open Access
File
431 Downloads (Pure)
Fruit consumption and the risk of bladder cancer: a pooled analysis by the BLadder cancer Epidemiology and Nutritional Determinants study
Jochems, S., Reulen, R., Van Osch, F., Witlox, W. J. A., Goossens, M. E., Brinkman, M., Giles, G. G., Milne, R. L., van den Brandt, P. A., White, E., Weiderpass, E., Huybrechts, I., Hémon, B., Agudo, A., Bueno-de-Mesquita, B., Cheng, K., van Schooten, F. J., Bryan, R., Wesselius, A. & Zeegers, M., 15 Oct 2020, In: International Journal of Cancer. 147, 8, p. 2091-2100 10 p.
Research output: Contribution to journal › Article › peer-review

Open Access
File
1 Citation (Scopus)

149 Downloads (Pure)
Gene-environment interaction with smoking for increased non-muscle-invasive bladder cancer tumor size
Lipunova, N., Wesselius, A., Cheng, K. K., van Schooten, F.-J., Bryan, R. T., Cazier, J.-B. & Zeegers, M. P., 30 Jun 2020, In: Translational Andrology and Urology. 9, 3, p. 1329-1337 9 p.
Research output: Contribution to journal › Article › peer-review

Open Access
File
205 Downloads (Pure)
Molecular subtypes of T1 bladder cancer: biomolecular characteristics versus clinical utility
Ward, D. G., Arnold, R. & Bryan, R. T., Oct 2020, In: European urology. 78, 4, p. 538-539 2 p.
Research output: Contribution to journal › Editorial › peer-review

Open Access
File

108 Downloads (Pure)
Prognostic DNA Methylation Biomarkers in High-risk Non–muscle-invasive Bladder Cancer: A Systematic Review to Identify Loci for Prospective Validation
Gurung, P. M. S., Barnett, A. R., Wilson, J. S., Hudson, J., Ward, D. G., Messing, E. M. & Bryan, R. T., 15 Jul 2020, In: European Urology Focus. 6, 4, p. 683-697 15 p.
Research output: Contribution to journal › Review article › peer-review

Open Access
File
3 Citations (Scopus)

11 Downloads (Pure)
The implementation and utility of patient screening logs in a multicentre randomised controlled oncology trial
Bryan, R. T. & POUT Trial Management Group, 8 Jul 2020, In: Trials. 21, 1, 11 p., 629.
Research output: Contribution to journal › Article › peer-review

Open Access
File
208 Downloads (Pure)

Rik Bryan, MRCS

Research output

Search results